25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Inovio Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyze Inovio together

I guess you are interested in Inovio Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Inovio Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Inovio Pharmaceuticals Inc

I send you an email if I find something interesting about Inovio Pharmaceuticals Inc.

1. Quick Overview

1.1. Quick analysis of Inovio (30 sec.)










1.2. What can you expect buying and holding a share of Inovio? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$2.61
Expected worth in 1 year
$-0.07
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-2.68
Return On Investment
-64.9%

For what price can you sell your share?

Current Price per Share
$4.13
Expected price per share
$3.85 - $5.79
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Inovio (5 min.)




Live pricePrice per Share (EOD)
$4.13
Intrinsic Value Per Share
$-147,135.05 - $-53,060.03
Total Value Per Share
$-147,132.44 - $-53,057.42

2.2. Growth of Inovio (5 min.)




Is Inovio growing?

Current yearPrevious yearGrowGrow %
How rich?$73.5m$182.2m-$86.7m-90.8%

How much money is Inovio making?

Current yearPrevious yearGrowGrow %
Making money-$6.3b$706.8m-$7b-111.2%
Net Profit Margin-14,087.8%624,868.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Inovio (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#402 / 949

Most Revenue
#701 / 949

Most Profit
#949 / 949

Most Efficient
#889 / 949
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Inovio?

Welcome investor! Inovio's management wants to use your money to grow the business. In return you get a share of Inovio.

First you should know what it really means to hold a share of Inovio. And how you can make/lose money.

Speculation

The Price per Share of Inovio is $4.13. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Inovio.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Inovio, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.61. Based on the TTM, the Book Value Change Per Share is $-0.67 per quarter. Based on the YOY, the Book Value Change Per Share is $1.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Inovio.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-894.28-21,653.3%-224.40-5,433.4%-1.58-38.2%-45.39-1,099.0%-22.81-552.2%
Usd Book Value Change Per Share-0.94-22.8%-0.67-16.2%1.0625.6%0.112.7%0.020.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.94-22.8%-0.67-16.2%1.0625.6%0.112.7%0.020.4%
Usd Price Per Share5.78-7.06-0.80-6.37-6.29-
Price to Earnings Ratio0.00--1.20--0.12--2.07--4.64-
Price-to-Total Gains Ratio-6.13--38.44--0.36--10.20--26.10-
Price to Book Ratio2.21-2.11-0.11-7.00-5.55-
Price-to-Total Gains Ratio-6.13--38.44--0.36--10.20--26.10-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.13
Number of shares242
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.670.11
Usd Total Gains Per Share-0.670.11
Gains per Quarter (242 shares)-162.1527.37
Gains per Year (242 shares)-648.60109.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-649-659010999
20-1297-13080219208
30-1946-19570328317
40-2594-26060438426
50-3243-32550547535
60-3892-39040657644
70-4540-45530766753
80-5189-52020876862
90-5837-58510985971
100-6486-6500010951080

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%2.038.00.05.0%5.098.00.04.9%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%8.032.00.020.0%27.076.00.026.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%2.00.038.05.0%16.00.087.015.5%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%8.032.00.020.0%28.075.00.027.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Inovio Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.944-0.670-29%1.056-189%0.113-934%0.017-5634%
Book Value Per Share--2.6133.571-27%6.984-63%3.146-17%2.379+10%
Current Ratio--3.8854.177-7%3.852+1%6.432-40%5.745-32%
Debt To Asset Ratio--0.3130.295+6%0.293+7%0.311+1%0.301+4%
Debt To Equity Ratio--0.4560.420+9%0.420+9%2.420-81%1.509-70%
Dividend Per Share----0%-0%-0%0.000-100%
Enterprise Value--213937476.660260819848.205-18%152732479.000+40%1072746174.604-80%809261976.350-74%
Eps---894.280-224.398-75%-1.576-100%-45.388-95%-22.806-97%
Ev To Ebitda Ratio---2.192-2.310+5%-0.930-58%-10.146+363%-8.503+288%
Ev To Sales Ratio--infinfnan%239.934+inf%infnan%infnan%
Free Cash Flow Per Share---2997.644-750.199-75%-1.366-100%-150.465-95%-75.329-97%
Free Cash Flow To Equity Per Share---2997.620-749.981-75%-1.272-100%-150.166-95%-75.084-97%
Gross Profit Margin--1.342166.822-99%1.000+34%34.164-96%17.582-92%
Intrinsic Value_10Y_max---53060.029--------
Intrinsic Value_10Y_min---147135.050--------
Intrinsic Value_1Y_max---1028.779--------
Intrinsic Value_1Y_min---3357.978--------
Intrinsic Value_3Y_max---6359.176--------
Intrinsic Value_3Y_min---20010.807--------
Intrinsic Value_5Y_max---15629.673--------
Intrinsic Value_5Y_min---47409.482--------
Market Cap107793000.000-51%162652072.660189497328.205-14%20981137.500+675%893246524.504-82%686268725.600-76%
Net Profit Margin----140.8780%6248.684-100%1125.823-100%554.499-100%
Operating Margin----140.1900%-269.4100%-159.3410%-87.7340%
Operating Ratio---149.580-100%342.917-100%238.286-100%134.708-100%
Pb Ratio1.580-40%2.2122.108+5%0.108+1944%7.001-68%5.546-60%
Pe Ratio-0.001+29%-0.002-1.203+74340%-0.119+7254%-2.074+128236%-4.640+287041%
Price Per Share4.130-40%5.7807.063-18%0.804+619%6.368-9%6.285-8%
Price To Free Cash Flow Ratio0.000+29%0.000-1.298+269102%-0.146+30114%-5.571+1155564%-6.424+1332505%
Price To Total Gains Ratio-4.377+29%-6.126-38.442+528%-0.358-94%-10.197+66%-26.097+326%
Quick Ratio--0.0065.495-100%6.608-100%9.632-100%8.908-100%
Return On Assets---235.060-58.920-75%2.646-8983%-11.342-95%-5.727-98%
Return On Equity---342.200-85.767-75%3.529-9798%-17.110-95%-8.656-97%
Total Gains Per Share---0.944-0.670-29%1.056-189%0.113-934%0.017-5601%
Usd Book Value--73540310.00095517652.250-23%182276929.750-60%256939679.050-71%190766793.150-61%
Usd Book Value Change Per Share---0.944-0.670-29%1.056-189%0.113-934%0.017-5634%
Usd Book Value Per Share--2.6133.571-27%6.984-63%3.146-17%2.379+10%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Eps---894.280-224.398-75%-1.576-100%-45.388-95%-22.806-97%
Usd Free Cash Flow---84355186862.000-21109649721.750-75%-35661371.750-100%-4258510742.000-95%-2137357493.125-97%
Usd Free Cash Flow Per Share---2997.644-750.199-75%-1.366-100%-150.465-95%-75.329-97%
Usd Free Cash Flow To Equity Per Share---2997.620-749.981-75%-1.272-100%-150.166-95%-75.084-97%
Usd Market Cap107793000.000-51%162652072.660189497328.205-14%20981137.500+675%893246524.504-82%686268725.600-76%
Usd Price Per Share4.130-40%5.7807.063-18%0.804+619%6.368-9%6.285-8%
Usd Profit---25165478000.000-6313297151.750-75%706897750.250-3660%-1158466273.150-95%-588663389.875-98%
Usd Revenue---50853.250-100%213506.500-100%1033025.300-100%4389812.750-100%
Usd Total Gains Per Share---0.944-0.670-29%1.056-189%0.113-934%0.017-5601%
 EOD+3 -5MRQTTM+4 -30YOY+8 -285Y+6 -2910Y+8 -29

3.3 Fundamental Score

Let's check the fundamental score of Inovio Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.001
Price to Book Ratio (EOD)Between0-11.580
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.006
Current Ratio (MRQ)Greater than13.885
Debt to Asset Ratio (MRQ)Less than10.313
Debt to Equity Ratio (MRQ)Less than10.456
Return on Equity (MRQ)Greater than0.15-342.200
Return on Assets (MRQ)Greater than0.05-235.060
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Inovio Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.559
Ma 20Greater thanMa 504.537
Ma 50Greater thanMa 1005.178
Ma 100Greater thanMa 2006.693
OpenGreater thanClose4.180
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

Fundamental data was last updated by Penke on 2024-12-04 19:00:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Inovio earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Inovio to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Inovio Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-14,087.8%+14,087.8%
TTM-14,087.8%YOY624,868.4%-638,956.2%
TTM-14,087.8%5Y112,582.3%-126,670.1%
5Y112,582.3%10Y55,449.9%+57,132.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--112.2%+112.2%
TTM-14,087.8%-221.4%-13,866.4%
YOY624,868.4%-210.0%+625,078.4%
5Y112,582.3%-342.2%+112,924.5%
10Y55,449.9%-464.5%+55,914.4%
4.3.1.2. Return on Assets

Shows how efficient Inovio is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Inovio to the Biotechnology industry mean.
  • -23,506.0% Return on Assets means that Inovio generated $-235.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Inovio Pharmaceuticals Inc:

  • The MRQ is -23,506.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5,892.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-23,506.0%TTM-5,892.0%-17,614.0%
TTM-5,892.0%YOY264.6%-6,156.7%
TTM-5,892.0%5Y-1,134.2%-4,757.9%
5Y-1,134.2%10Y-572.7%-561.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-23,506.0%-11.3%-23,494.7%
TTM-5,892.0%-11.7%-5,880.3%
YOY264.6%-11.3%+275.9%
5Y-1,134.2%-12.7%-1,121.5%
10Y-572.7%-14.1%-558.6%
4.3.1.3. Return on Equity

Shows how efficient Inovio is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Inovio to the Biotechnology industry mean.
  • -34,220.0% Return on Equity means Inovio generated $-342.20 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Inovio Pharmaceuticals Inc:

  • The MRQ is -34,220.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8,576.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-34,220.0%TTM-8,576.7%-25,643.3%
TTM-8,576.7%YOY352.9%-8,929.6%
TTM-8,576.7%5Y-1,711.0%-6,865.7%
5Y-1,711.0%10Y-865.6%-845.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-34,220.0%-14.2%-34,205.8%
TTM-8,576.7%-15.9%-8,560.8%
YOY352.9%-14.3%+367.2%
5Y-1,711.0%-18.5%-1,692.5%
10Y-865.6%-19.3%-846.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Inovio Pharmaceuticals Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Inovio is operating .

  • Measures how much profit Inovio makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Inovio to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Inovio Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-14,019.0%+14,019.0%
TTM-14,019.0%YOY-26,941.0%+12,922.0%
TTM-14,019.0%5Y-15,934.1%+1,915.0%
5Y-15,934.1%10Y-8,773.4%-7,160.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--222.9%+222.9%
TTM-14,019.0%-310.7%-13,708.3%
YOY-26,941.0%-223.5%-26,717.5%
5Y-15,934.1%-387.1%-15,547.0%
10Y-8,773.4%-498.5%-8,274.9%
4.3.2.2. Operating Ratio

Measures how efficient Inovio is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Inovio Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM149.580-149.580
TTM149.580YOY342.917-193.336
TTM149.5805Y238.286-88.706
5Y238.28610Y134.708+103.578
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.465-2.465
TTM149.5803.253+146.327
YOY342.9173.298+339.619
5Y238.2864.788+233.498
10Y134.7086.494+128.214
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Inovio Pharmaceuticals Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Inovio is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.88 means the company has $3.88 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Inovio Pharmaceuticals Inc:

  • The MRQ is 3.885. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.177. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.885TTM4.177-0.292
TTM4.177YOY3.852+0.325
TTM4.1775Y6.432-2.255
5Y6.43210Y5.745+0.687
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8853.637+0.248
TTM4.1773.890+0.287
YOY3.8524.666-0.814
5Y6.4325.953+0.479
10Y5.7456.277-0.532
4.4.3.2. Quick Ratio

Measures if Inovio is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Inovio to the Biotechnology industry mean.
  • A Quick Ratio of 0.01 means the company can pay off $0.01 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Inovio Pharmaceuticals Inc:

  • The MRQ is 0.006. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 5.495. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.006TTM5.495-5.489
TTM5.495YOY6.608-1.113
TTM5.4955Y9.632-4.137
5Y9.63210Y8.908+0.724
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0063.086-3.080
TTM5.4953.451+2.044
YOY6.6084.456+2.152
5Y9.6325.931+3.701
10Y8.9086.436+2.472
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Inovio Pharmaceuticals Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Inovio assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Inovio to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.31 means that Inovio assets are financed with 31.3% credit (debt) and the remaining percentage (100% - 31.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Inovio Pharmaceuticals Inc:

  • The MRQ is 0.313. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.295. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.313TTM0.295+0.018
TTM0.295YOY0.293+0.002
TTM0.2955Y0.311-0.016
5Y0.31110Y0.301+0.010
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3130.350-0.037
TTM0.2950.344-0.049
YOY0.2930.310-0.017
5Y0.3110.365-0.054
10Y0.3010.382-0.081
4.5.4.2. Debt to Equity Ratio

Measures if Inovio is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Inovio to the Biotechnology industry mean.
  • A Debt to Equity ratio of 45.6% means that company has $0.46 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Inovio Pharmaceuticals Inc:

  • The MRQ is 0.456. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.420. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.456TTM0.420+0.036
TTM0.420YOY0.420+0.000
TTM0.4205Y2.420-2.000
5Y2.42010Y1.509+0.910
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4560.394+0.062
TTM0.4200.432-0.012
YOY0.4200.380+0.040
5Y2.4200.451+1.969
10Y1.5090.490+1.019
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Inovio generates.

  • Above 15 is considered overpriced but always compare Inovio to the Biotechnology industry mean.
  • A PE ratio of 0.00 means the investor is paying $0.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Inovio Pharmaceuticals Inc:

  • The EOD is -0.001. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.002. Based on the earnings, the company is expensive. -2
  • The TTM is -1.203. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.001MRQ-0.002+0.000
MRQ-0.002TTM-1.203+1.201
TTM-1.203YOY-0.119-1.084
TTM-1.2035Y-2.074+0.871
5Y-2.07410Y-4.640+2.566
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.001-2.253+2.252
MRQ-0.002-2.411+2.409
TTM-1.203-3.149+1.946
YOY-0.119-3.274+3.155
5Y-2.074-6.143+4.069
10Y-4.640-6.785+2.145
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Inovio Pharmaceuticals Inc:

  • The EOD is 0.000. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 0.000. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.298. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ0.000+0.000
MRQ0.000TTM-1.298+1.297
TTM-1.298YOY-0.146-1.152
TTM-1.2985Y-5.571+4.273
5Y-5.57110Y-6.424+0.853
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-3.009+3.009
MRQ0.000-3.259+3.259
TTM-1.298-3.730+2.432
YOY-0.146-4.574+4.428
5Y-5.571-8.371+2.800
10Y-6.424-9.287+2.863
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Inovio is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.21 means the investor is paying $2.21 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Inovio Pharmaceuticals Inc:

  • The EOD is 1.580. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.212. Based on the equity, the company is underpriced. +1
  • The TTM is 2.108. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.580MRQ2.212-0.631
MRQ2.212TTM2.108+0.104
TTM2.108YOY0.108+2.000
TTM2.1085Y7.001-4.893
5Y7.00110Y5.546+1.455
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.5801.979-0.399
MRQ2.2122.051+0.161
TTM2.1082.365-0.257
YOY0.1082.455-2.347
5Y7.0013.726+3.275
10Y5.5464.378+1.168
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Inovio Pharmaceuticals Inc.

4.8.1. Institutions holding Inovio Pharmaceuticals Inc

Institutions are holding 33.512% of the shares of Inovio Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Deep Track Capital, LP6.91330.33081804366-262354-12.6942
2024-09-30Vanguard Group Inc6.88870.0002179796021638913.6819
2024-06-30BlackRock Inc6.5380.000317064201366734402.3522
2024-09-30Geode Capital Management, LLC2.38170.0003621631388336.6632
2024-09-30State Street Corp1.87990.00014906625141411.705
2024-09-30Renaissance Technologies Corp1.26850.0029331066-79500-19.3635
2024-09-30Northern Trust Corp0.78850.0002205788144676236.7391
2024-09-30Dimensional Fund Advisors, Inc.0.50.00021305105565274.3434
2024-09-30GMT Capital Corp0.48320.02911261211261210
2024-06-30Susquehanna Fundamental Investments, LLC0.38310.018699991-6800-6.3676
2024-09-30Morgan Stanley - Brokerage Accounts0.3645095132-112280-54.1338
2024-09-30Deerfield Management Co0.29320.006676523765230
2024-09-30Goldman Sachs Group Inc0.28040.0001731903078972.6139
2024-09-30Charles Schwab Investment Management Inc0.27230.000171066-33-0.0464
2024-09-30Wellington Management Company LLP0.25150.000165633656330
2024-09-30Bank of New York Mellon Corp0.23450.000161213-20622-25.1995
2024-09-30Squarepoint Ops LLC0.19740.000551528515280
2024-09-30Nuveen Asset Management, LLC0.17810.00014649100
2024-09-30American Century Companies Inc0.15640.000140824925929.3331
2024-06-30Bank of America Corp0.1470383578002.1301
Total 30.40020.39047934472+1752762+22.1%

4.9.2. Funds holding Inovio Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-10-31Vanguard Total Stock Mkt Idx Inv3.13720.000381881700
2024-11-27iShares Russell 2000 ETF2.80870.0038733070-1526-0.2077
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr1.40420.001836650100
2024-11-27iShares Russell 2000 Value ETF1.02090.0082664543440.1293
2024-08-31Fidelity Small Cap Index0.99750.0069260341-6974-2.6089
2024-09-30Vanguard Strategic Equity Inv0.95840.01625014400
2024-10-31State St Russell Sm/Mid Cp® Indx NL Cl C0.58750.0018153336-5300-3.341
2024-09-30Fidelity Extended Market Index0.58080.0021151576-865-0.5674
2024-10-31Vanguard Russell 2000 ETF0.45890.0052119760-748-0.6207
2024-10-31State St Russell Sm Cap® Indx SL Cl I0.42220.00611020000
2024-10-31Vanguard Health Care ETF0.33040.002286228-224-0.2591
2024-09-30NT R2000 Index Fund - NL0.2470.005764459644590
2024-11-27iShares Micro-Cap ETF0.2320.02556054700
2024-09-30BlackRock Extended Equity Market K0.23130.002460366-26-0.0431
2024-10-31Schwab Small Cap Index0.22990.0055999100
2024-09-30Northern Trust Russell 2000 Value Index0.20510.011653519535190
2024-09-30NT R2000 Value Index Fund - L0.20510.011553519535190
2024-09-30NT R2000 Index Fund - DC - NL - 20.19780.005751615516150
2024-10-31iShares Russell 2000 Small-Cap Idx Instl0.1940.00555063600
2024-09-30Fidelity Total Market Index0.18250.000347621647115.7254
Total 14.63140.12733818700+214264+5.6%

5.3. Insider Transactions

Insiders are holding 0.847% of the shares of Inovio Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-03-13David B WeinerSELL40165.6
2023-02-27David B WeinerSELL81184.32
2022-08-11David B WeinerSELL82383.04
2022-07-20Simon X BenitoSELL13324
2022-03-16Simon X BenitoSELL13455.04
2022-03-14David B WeinerSELL28460.8
2022-01-19Simon X BenitoSELL13614.88
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets107,060
Total Liabilities33,519
Total Stockholder Equity73,540
 As reported
Total Liabilities 33,519
Total Stockholder Equity+ 73,540
Total Assets = 107,060

Assets

Total Assets107,060
Total Current Assets91,284,623
Long-term Assets15,775
Total Current Assets
Cash And Cash Equivalents 21,687,480
Short-term Investments 63,117
Net Receivables 1,863
Inventory 86,576,222
Total Current Assets  (as reported)91,284,623
Total Current Assets  (calculated)108,328,682
+/- 17,044,059
Long-term Assets
Property Plant Equipment 12,564
Long Term Investments 2,644
Long-term Assets Other 566
Long-term Assets  (as reported)15,775
Long-term Assets  (calculated)15,775
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities23,499,137
Long-term Liabilities10,020
Total Stockholder Equity73,540
Total Current Liabilities
Short-term Debt 2,427,537
Accounts payable 5,386
Other Current Liabilities 21,066,214
Total Current Liabilities  (as reported)23,499,137
Total Current Liabilities  (calculated)23,499,137
+/-0
Long-term Liabilities
Capital Lease Obligations 12,445
Long-term Liabilities  (as reported)10,020
Long-term Liabilities  (calculated)12,445
+/- 2,425
Total Stockholder Equity
Common Stock26,051
Retained Earnings -1,710,838
Accumulated Other Comprehensive Income -623
Other Stockholders Equity 1,758,950
Total Stockholder Equity (as reported)73,540
Total Stockholder Equity (calculated)73,540
+/-0
Other
Capital Stock26
Cash and Short Term Investments 84,805
Common Stock Shares Outstanding 28,140
Liabilities and Stockholders Equity 107,060
Net Debt -9,242,141
Net Invested Capital 73,540
Net Working Capital 67,785
Property Plant and Equipment Gross 12,564
Short Long Term Debt Total 12,445,339



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-31
> Total Assets 
12,100
9,800
18,200
16,600
15,200
14,012
12,712
11,012
9,184
11,484
8,907
7,064
11,484
4,256
7,881
6,552
5,419
4,979
3,653
9,953
16,229
15,685
24,676
22,627
20,952
22,881
20,149
15,916
28,979
25,978
23,025
19,902
35,950
31,919
44,353
40,865
39,775
35,717
32,265
30,481
38,987
35,984
63,273
90,438
80,629
79,722
60,277
59,317
56,067
74,854
67,858
63,266
61,107
55,351
48,596
44,476
45,139
58,201
50,993
88,015
88,287
151,658
142,153
134,533
131,785
117,855
201,703
230,772
213,841
211,288
203,985
194,549
173,707
153,314
158,853
203,680
187,239
173,665
148,923
140,696
131,113
191,166
165,073
151,533
143,952
338,921
443,185
437,814
539,772
654,863
591,842
535,763
495,941
445,511
459,399
391,968
348,533
266,583
233,038
193,097
172,944
129,114
133,797
107,060
107,060133,797129,114172,944193,097233,038266,583348,533391,968459,399445,511495,941535,763591,842654,863539,772437,814443,185338,921143,952151,533165,073191,166131,113140,696148,923173,665187,239203,680158,853153,314173,707194,549203,985211,288213,841230,772201,703117,855131,785134,533142,153151,65888,28788,01550,99358,20145,13944,47648,59655,35161,10763,26667,85874,85456,06759,31760,27779,72280,62990,43863,27335,98438,98730,48132,26535,71739,77540,86544,35331,91935,95019,90223,02525,97828,97915,91620,14922,88120,95222,62724,67615,68516,2299,9533,6534,9795,4196,5527,8814,25611,4847,0648,90711,4849,18411,01212,71214,01215,20016,60018,2009,80012,100
   > Total Current Assets 
9,900
7,600
15,900
14,400
12,900
11,614
10,290
8,050
5,821
8,247
5,772
3,867
8,247
3,608
5,114
3,832
2,698
2,357
1,093
7,438
13,752
13,217
22,239
20,203
18,439
12,989
10,327
6,188
18,321
15,289
12,139
9,102
24,472
20,430
32,985
29,621
29,004
12,369
9,229
7,900
15,264
12,425
24,258
48,431
44,567
43,122
27,316
24,272
22,877
42,483
38,607
32,734
31,907
26,936
21,317
16,934
15,968
30,316
25,537
57,854
58,684
121,684
112,944
104,637
98,947
87,330
162,141
184,073
171,851
160,601
147,970
140,230
124,597
106,779
106,878
154,588
138,362
123,836
101,841
93,603
87,815
134,903
110,509
98,813
94,201
275,544
382,062
377,065
471,171
588,435
542,425
487,397
448,445
399,907
416,185
350,208
315,243
233,896
203,284
174,767
153,113
111,683
117,561
91,284,623
91,284,623117,561111,683153,113174,767203,284233,896315,243350,208416,185399,907448,445487,397542,425588,435471,171377,065382,062275,54494,20198,813110,509134,90387,81593,603101,841123,836138,362154,588106,878106,779124,597140,230147,970160,601171,851184,073162,14187,33098,947104,637112,944121,68458,68457,85425,53730,31615,96816,93421,31726,93631,90732,73438,60742,48322,87724,27227,31643,12244,56748,43124,25812,42515,2647,9009,22912,36929,00429,62132,98520,43024,4729,10212,13915,28918,3216,18810,32712,98918,43920,20322,23913,21713,7527,4381,0932,3572,6983,8325,1143,6088,2473,8675,7728,2475,8218,05010,29011,61412,90014,40015,9007,6009,900
       Cash And Cash Equivalents 
8,800
6,200
14,500
3,800
4,500
9,742
8,253
6,028
3,287
3,721
4,005
2,206
3,721
1,813
1,429
1,365
875
2,023
924
7,359
13,460
13,129
22,068
19,740
17,890
11,810
6,909
4,977
17,167
2,220
1,873
1,940
8,322
6,334
7,786
7,087
10,251
8,282
8,107
6,411
14,115
11,727
8,283
32,509
30,296
17,711
14,952
19,392
19,998
37,182
30,594
25,303
17,350
11,129
5,952
4,589
5,646
20,087
10,352
33,067
33,720
98,771
88,535
70,669
40,544
26,146
70,298
85,469
57,633
41,624
28,450
23,251
19,136
22,903
23,861
23,278
23,787
37,509
15,086
19,398
23,694
20,779
19,736
15,853
22,196
158,447
215,433
178,700
250,728
83,634
58,925
67,941
71,144
59,009
41,102
21,988
46,329
28,238
52,713
18,805
14,311
19,602
34,392
21,687,480
21,687,48034,39219,60214,31118,80552,71328,23846,32921,98841,10259,00971,14467,94158,92583,634250,728178,700215,433158,44722,19615,85319,73620,77923,69419,39815,08637,50923,78723,27823,86122,90319,13623,25128,45041,62457,63385,46970,29826,14640,54470,66988,53598,77133,72033,06710,35220,0875,6464,5895,95211,12917,35025,30330,59437,18219,99819,39214,95217,71130,29632,5098,28311,72714,1156,4118,1078,28210,2517,0877,7866,3348,3221,9401,8732,22017,1674,9776,90911,81017,89019,74022,06813,12913,4607,3599242,0238751,3651,4291,8133,7212,2064,0053,7213,2876,0288,2539,7424,5003,80014,5006,2008,800
       Short-term Investments 
0
0
0
8,800
6,400
0
0
0
688
2,804
0
0
2,804
0
1,989
994
0
0
0
0
0
0
0
0
0
0
0
0
0
12,000
9,000
5,700
14,700
12,700
23,811
21,363
17,000
2,991
0
0
0
0
13,512
10,420
13,543
18,836
9,748
4,110
1,846
3,664
5,760
5,764
12,863
13,730
13,487
10,555
8,034
7,978
13,108
13,105
18,906
18,011
20,323
30,259
53,076
54,867
84,296
85,314
105,357
105,163
106,083
96,436
85,629
66,755
68,139
118,612
103,639
75,260
80,509
66,097
57,539
107,216
86,236
77,946
67,338
111,551
156,231
158,536
160,915
434,970
384,752
326,999
330,171
301,384
307,023
259,895
206,669
195,513
142,213
148,669
130,983
86,013
76,029
63,117
63,11776,02986,013130,983148,669142,213195,513206,669259,895307,023301,384330,171326,999384,752434,970160,915158,536156,231111,55167,33877,94686,236107,21657,53966,09780,50975,260103,639118,61268,13966,75585,62996,436106,083105,163105,35785,31484,29654,86753,07630,25920,32318,01118,90613,10513,1087,9788,03410,55513,48713,73012,8635,7645,7603,6641,8464,1109,74818,83613,54310,42013,51200002,99117,00021,36323,81112,70014,7005,7009,00012,00000000000000009941,98902,804002,8046880006,4008,800000
       Net Receivables 
500
800
600
800
1,000
1,120
999
982
823
904
792
849
904
940
55
9
76
171
3
0
175
7
0
351
424
461
2,524
282
284
432
385
304
326
249
363
293
1,140
477
561
740
671
243
1,420
1,339
318
3,405
2,188
216
105
170
438
455
506
916
466
616
867
1,073
540
10,574
3,302
2,718
2,877
1,622
2,804
3,300
5,609
10,965
7,333
11,153
10,366
17,455
16,570
11,098
8,712
7,162
6,490
7,390
2,673
4,399
4,055
4,079
1,127
1,755
2,032
1,276
3,996
8,194
19,064
10,259
13,851
7,125
8,032
7,491
11,372
2,443
11,738
5,035
5,116
2,144
2,405
2,551
1,774
1,863
1,8631,7742,5512,4052,1445,1165,03511,7382,44311,3727,4918,0327,12513,85110,25919,0648,1943,9961,2762,0321,7551,1274,0794,0554,3992,6737,3906,4907,1628,71211,09816,57017,45510,36611,1537,33310,9655,6093,3002,8041,6222,8772,7183,30210,5745401,0738676164669165064554381701052162,1883,4053181,3391,4202436717405614771,1402933632493263043854322842822,5244614243510717503171769559409048497929048239829991,1201,000800600800500
       Inventory 
500
700
800
800
900
612
837
978
962
757
876
763
757
848
22
30
229
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
178
178
0
464
0
0
0
0
0
0
0
0
0
0
63
63
63
63
62
62
62
62
343
343
343
343
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,231
0
0
0
0
86,576,222
86,576,22200003,23100000000000000000000000000000034334334334362626262636363630000000000464017817800000000000000000000000002293022848757763876757962978837612900800800700500
       Other Current Assets 
100
-100
0
200
100
139
200
63
61
61
99
48
6
6
1,618
1,433
1,517
163
165
79
117
81
171
112
125
717
893
929
870
637
880
1,158
1,124
1,147
1,026
879
614
619
561
748
477
454
866
3,114
410
2,706
428
555
927
1,467
1,814
1,212
1,187
1,162
1,412
1,174
1,358
1,116
1,474
1,045
2,695
2,122
1,147
2,024
2,180
2,675
1,597
1,983
1,528
2,661
3,070
3,088
3,261
6,023
6,166
5,536
4,447
3,677
3,572
3,709
2,527
2,828
3,410
3,259
2,635
4,270
6,403
31,634
40,464
59,572
84,896
85,331
39,098
32,022
56,689
65,882
50,506
5,110
12
5,150
5,414
3,517
5,366
4,621,733
4,621,7335,3663,5175,4145,150125,11050,50665,88256,68932,02239,09885,33184,89659,57240,46431,6346,4034,2702,6353,2593,4102,8282,5273,7093,5723,6774,4475,5366,1666,0233,2613,0883,0702,6611,5281,9831,5972,6752,1802,0241,1472,1222,6951,0451,4741,1161,3581,1741,4121,1621,1871,2121,8141,4679275554282,7064103,1148664544777485616196148791,0261,1471,1241,15888063787092989371712511217181117791651631,5171,4331,6186648996161632001391002000-100100
   > Long-term Assets 
2,200
2,200
2,300
2,200
2,300
2,398
2,422
2,961
3,363
3,237
3,136
3,197
3,237
648
2,767
2,720
2,721
2,622
2,560
2,515
2,477
2,468
2,438
2,423
2,513
9,892
9,823
9,728
10,658
10,689
10,887
10,801
11,478
11,489
11,368
11,244
10,771
23,348
23,036
22,582
23,723
23,559
39,015
42,007
36,062
36,599
32,961
35,045
33,190
32,371
29,251
30,533
29,199
28,415
27,279
27,542
29,171
27,885
25,456
30,161
29,604
29,973
29,209
29,896
32,838
30,526
39,562
46,698
41,990
50,687
56,016
54,319
49,110
46,535
51,976
49,092
48,877
49,829
47,082
47,094
43,298
56,263
54,564
52,721
49,751
63,377
61,123
60,749
68,602
66,429
49,418
48,366
47,497
45,604
43,214
41,760
33,291
32,686
29,753
18,330
19,831
17,431
16,236
15,775
15,77516,23617,43119,83118,33029,75332,68633,29141,76043,21445,60447,49748,36649,41866,42968,60260,74961,12363,37749,75152,72154,56456,26343,29847,09447,08249,82948,87749,09251,97646,53549,11054,31956,01650,68741,99046,69839,56230,52632,83829,89629,20929,97329,60430,16125,45627,88529,17127,54227,27928,41529,19930,53329,25132,37133,19035,04532,96136,59936,06242,00739,01523,55923,72322,58223,03623,34810,77111,24411,36811,48911,47810,80110,88710,68910,6589,7289,8239,8922,5132,4232,4382,4682,4772,5152,5602,6222,7212,7202,7676483,2373,1973,1363,2373,3632,9612,4222,3982,3002,2002,3002,2002,200
       Property Plant Equipment 
1,200
1,200
1,100
1,000
900
1,015
989
973
994
904
834
731
648
648
434
366
295
249
218
198
176
153
165
170
155
423
405
411
376
507
471
459
391
414
386
371
402
378
403
404
354
309
466
382
343
340
383
341
277
304
306
289
296
355
422
392
363
363
348
2,291
2,887
3,021
4,549
4,634
4,583
4,947
5,497
6,459
7,307
8,393
8,701
8,991
9,025
9,803
15,018
18,471
18,320
17,486
16,869
16,228
15,949
29,618
28,488
27,519
26,556
25,616
24,589
24,199
24,089
23,393
30,285
29,457
29,024
27,948
27,126
26,165
17,956
16,849
15,793
14,730
14,453
14,172
13,330
12,564
12,56413,33014,17214,45314,73015,79316,84917,95626,16527,12627,94829,02429,45730,28523,39324,08924,19924,58925,61626,55627,51928,48829,61815,94916,22816,86917,48618,32018,47115,0189,8039,0258,9918,7018,3937,3076,4595,4974,9474,5834,6344,5493,0212,8872,2913483633633924223552962893063042773413833403433824663093544044033784023713864143914594715073764114054231551701651531761982182492953664346486487318349049949739891,0159001,0001,1001,2001,200
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,157
3,157
3,157
4,291
4,291
4,291
4,291
4,291
4,291
4,291
4,291
3,901
3,901
3,901
3,901
3,901
3,901
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
0
0
0
0
0
0000010,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,1133,9013,9013,9013,9013,9013,9014,2914,2914,2914,2914,2914,2914,2914,2913,1573,1573,1570000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,384
10,149
9,172
8,804
0
0
0
0
0
0
0
0
0
0
12,891
0
0
0
19,993
0
0
0
19,830
0
0
0
9,069
13,775
11,682
12,700
6,382
6,430
6,325
7,997
6,315
21,211
2,717
958
434
3,630
3,909
3,887
3,907
3,369
2,435
2,130
2,007
2,624
2,781
2,995
2,780
2,654
2,320
2,644
2,6442,3202,6542,7802,9952,7812,6242,0072,1302,4353,3693,9073,8873,9093,6304349582,71721,2116,3157,9976,3256,4306,38212,70011,68213,7759,06900019,83000019,99300012,89100000000008,8049,17210,1498,38400000000000000000000000000000000000000000000000000
       Intangible Assets 
0
1,000
0
0
0
1,350
0
0
0
2,306
0
0
2,351
0
0
0
2,426
2,426
0
0
2,253
0
0
0
2,358
9,469
9,417
9,317
5,992
5,892
6,125
6,051
6,664
6,784
6,691
6,301
6,186
6,066
5,962
5,938
10,132
9,648
13,942
13,453
12,969
12,488
12,133
11,655
11,180
10,709
10,239
9,773
9,310
8,850
8,393
7,940
7,489
7,041
6,596
6,157
5,719
5,479
5,241
5,007
4,776
4,553
4,333
4,118
3,906
3,696
8,449
8,037
7,628
7,222
6,818
6,414
6,010
5,606
5,293
5,027
4,760
4,494
4,227
3,960
3,694
3,557
3,420
3,284
3,147
3,010
2,880
2,753
2,626
2,500
2,369
2,249
2,130
2,048
0
0
0
0
0
0
0000002,0482,1302,2492,3692,5002,6262,7532,8803,0103,1473,2843,4203,5573,6943,9604,2274,4944,7605,0275,2935,6066,0106,4146,8187,2227,6288,0378,4493,6963,9064,1184,3334,5534,7765,0075,2415,4795,7196,1576,5967,0417,4897,9408,3938,8509,3109,77310,23910,70911,18011,65512,13312,48812,96913,45313,9429,64810,1325,9385,9626,0666,1866,3016,6916,7846,6646,0516,1255,8925,9929,3179,4179,4692,3580002,253002,4262,4260002,351002,3060001,3500001,0000
       Long-term Assets Other 
1,000
0
1,200
1,200
1,400
33
1,433
1,988
2,368
2,333
2,302
2,466
2,333
2,393
2,333
2,354
0
2,373
2,342
2,317
2,301
2,315
2,273
2,253
2,358
2,358
0
0
0
0
0
0
132
132
0
282
282
13,003
12,770
12,340
167
167
287
287
306
283
284
284
259
254
208
445
408
292
323
323
439
438
501
454
1,158
2,010
1,414
1,082
-342,571,975
582
425
344
671
1,035
1,326
1,482
2,113
1,525
1,674
2,197
2,639
2,449
2,724
2,626
2,670
2,981
2,853
2,731
2,672
2,480
2,556
17,642
25,957
25,882
1,831
1,755
-1,540
1,274
770
2,832
-1,631
653
667
605
605
605
586
566
566586605605605667653-1,6312,8327701,274-1,5401,7551,83125,88225,95717,6422,5562,4802,6722,7312,8532,9812,6702,6262,7242,4492,6392,1971,6741,5252,1131,4821,3261,035671344425582-342,571,9751,0821,4142,0101,15845450143843932332329240844520825425928428428330628728716716712,34012,77013,00328228201321320000002,3582,3582,2532,2732,3152,3012,3172,3422,37302,3542,3332,3932,3332,4662,3022,3332,3681,9881,433331,4001,2001,20001,000
> Total Liabilities 
1,300
1,500
1,400
1,800
2,100
2,181
2,025
1,645
1,631
1,596
1,583
1,455
1,596
1,671
1,230
1,285
1,694
917
786
1,035
1,181
840
1,841
3,278
5,402
5,653
5,176
4,061
5,508
4,566
4,166
4,010
8,907
8,171
8,335
8,334
8,740
8,118
8,698
9,480
19,881
20,166
25,416
22,253
19,444
20,402
8,325
7,785
8,966
16,601
12,276
11,962
13,245
15,121
12,237
13,196
10,281
17,781
21,321
25,799
35,385
22,478
19,885
17,488
20,248
14,429
20,745
37,386
37,908
40,071
41,896
47,571
50,329
47,369
35,324
41,561
44,750
60,570
37,431
36,987
44,081
110,199
108,595
115,415
138,547
151,067
256,825
113,814
78,632
73,257
83,288
82,190
96,272
90,426
161,728
125,271
126,171
67,369
63,666
54,937
55,595
34,672
37,058
33,519
33,51937,05834,67255,59554,93763,66667,369126,171125,271161,72890,42696,27282,19083,28873,25778,632113,814256,825151,067138,547115,415108,595110,19944,08136,98737,43160,57044,75041,56135,32447,36950,32947,57141,89640,07137,90837,38620,74514,42920,24817,48819,88522,47835,38525,79921,32117,78110,28113,19612,23715,12113,24511,96212,27616,6018,9667,7858,32520,40219,44422,25325,41620,16619,8819,4808,6988,1188,7408,3348,3358,1718,9074,0104,1664,5665,5084,0615,1765,6535,4023,2781,8418401,1811,0357869171,6941,2851,2301,6711,5961,4551,5831,5961,6311,6452,0252,1812,1001,8001,4001,5001,300
   > Total Current Liabilities 
1,100
1,400
1,200
1,700
2,100
2,106
1,956
1,583
1,538
1,513
1,505
1,387
1,513
1,605
1,183
1,244
1,658
884
756
1,009
1,159
824
1,831
3,274
5,402
5,310
4,849
3,749
4,136
3,235
2,858
2,735
3,268
2,705
2,973
3,106
3,354
2,855
3,547
4,455
14,710
15,074
20,034
21,246
19,350
17,688
5,672
5,225
6,437
14,184
9,941
9,704
11,043
13,015
10,231
11,276
8,377
15,978
19,071
20,438
28,966
15,641
11,604
8,928
14,024
8,159
14,520
18,278
31,466
33,399
35,495
41,375
43,823
40,003
27,382
33,364
35,405
51,375
28,406
27,998
35,300
27,415
24,079
19,547
31,989
32,295
37,982
41,263
41,706
41,539
51,749
51,376
65,742
59,360
131,064
94,915
96,868
55,151
51,932
43,711
42,570
23,401
26,400
23,499,137
23,499,13726,40023,40142,57043,71151,93255,15196,86894,915131,06459,36065,74251,37651,74941,53941,70641,26337,98232,29531,98919,54724,07927,41535,30027,99828,40651,37535,40533,36427,38240,00343,82341,37535,49533,39931,46618,27814,5208,15914,0248,92811,60415,64128,96620,43819,07115,9788,37711,27610,23113,01511,0439,7049,94114,1846,4375,2255,67217,68819,35021,24620,03415,07414,7104,4553,5472,8553,3543,1062,9732,7053,2682,7352,8583,2354,1363,7494,8495,3105,4023,2741,8318241,1591,0097568841,6581,2441,1831,6051,5131,3871,5051,5131,5381,5831,9562,1062,1001,7001,2001,4001,100
       Short-term Debt 
0
0
0
0
100
53
54
55
73
69
60
38
69
20
22
22
21
0
0
815
331
555
662
0
3,067
0
0
0
0
0
0
0
0
720
776
653
0
617
594
1,764
12,109
12,072
12,088
12,112
12,115
12,098
1,013
0
0
0
1,184
0
4,258
856
1,214
1,495
3,735
2,200
1,732
1,359
5,025
1,735
1,719
1,260
6,388
1,407
2,740
3,140
11,754
4,467
5,398
7,616
20,492
6,527
7,870
8,689
25,203
9,357
14,149
0
0
1,889
1,949
2,011
2,075
2,132
2,200
2,264
2,329
2,396
2,464
2,536
2,604
2,673
2,738
2,821
2,804
18,975
19,060
18,606
19,177
2,156
2,322
2,427,537
2,427,5372,3222,15619,17718,60619,06018,9752,8042,8212,7382,6732,6042,5362,4642,3962,3292,2642,2002,1322,0752,0111,9491,8890014,1499,35725,2038,6897,8706,52720,4927,6165,3984,46711,7543,1402,7401,4076,3881,2601,7191,7355,0251,3591,7322,2003,7351,4951,2148564,25801,1840001,01312,09812,11512,11212,08812,07212,1091,7645946170653776720000000003,0670662555331815002122222069386069735554531000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,889
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,395
16,708
16,488
16,771
0
0
0
00016,77116,48816,70816,3950000000000000001,889000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
1,100
1,400
1,200
1,700
1,800
1,784
1,633
1,277
1,321
1,394
1,423
1,330
625
1,154
684
628
1,033
682
560
815
828
555
662
378
677
1,673
1,891
1,303
1,865
1,579
1,430
1,445
555
1,475
1,649
1,894
1,807
1,365
1,881
1,478
377
2,266
41
594
1,568
3,345
3,158
3,495
1,564
3,337
3,243
4,710
1,140
3,317
3,523
3,134
1,040
2,945
3,382
4,515
2,388
6,030
5,991
4,792
2,031
4,450
9,485
13,332
4,457
12,310
13,309
16,677
6,993
14,995
17,325
23,310
8,492
17,124
13,211
18,016
11,022
16,960
14,042
10,247
7,649
11,283
17,729
24,328
1,468
26,743
31,869
29,147
24,762
39,523
39,575
74,148
80,907
26,169
10,356
3,904
4,648
8,297
6,409
5,386
5,3866,4098,2974,6483,90410,35626,16980,90774,14839,57539,52324,76229,14731,86926,7431,46824,32817,72911,2837,64910,24714,04216,96011,02218,01613,21117,1248,49223,31017,32514,9956,99316,67713,30912,3104,45713,3329,4854,4502,0314,7925,9916,0302,3884,5153,3822,9451,0403,1343,5233,3171,1404,7103,2433,3371,5643,4953,1583,3451,568594412,2663771,4781,8811,3651,8071,8941,6491,4755551,4451,4301,5791,8651,3031,8911,6736773786625558288155606821,0336286841,1546251,3301,4231,3941,3211,2771,6331,7841,8001,7001,2001,4001,100
       Other Current Liabilities 
0
0
0
0
200
269
269
251
144
536
22
19
953
1,490
337
393
402
202
196
815
-331
555
662
1,824
607
2,554
1,350
1,103
1,064
656
504
614
2,130
69
69
62
574
405
524
716
1,614
161
5,212
7,673
5,397
1,718
1,049
4,365
5,641
13,544
4,868
9,230
5,176
8,417
5,039
6,163
2,860
10,255
13,454
14,096
19,541
6,046
3,107
2,207
2,023
1,733
1,710
1,094
1,301
1,707
1,815
1,813
1,168
1,051
1,364
940
361
750
229
9,721
24,021
8,453
7,872
7,118
22,142
18,812
17,944
14,593
37,861
12,346
17,307
19,615
38,354
17,149
79,769
17,946
13,157
10,007
3,749
21,201
18,745
12,948
17,669
21,066,214
21,066,21417,66912,94818,74521,2013,74910,00713,15717,94679,76917,14938,35419,61517,30712,34637,86114,59317,94418,81222,1427,1187,8728,45324,0219,7212297503619401,3641,0511,1681,8131,8151,7071,3011,0941,7101,7332,0232,2073,1076,04619,54114,09613,45410,2552,8606,1635,0398,4175,1769,2304,86813,5445,6414,3651,0491,7185,3977,6735,2121611,6147165244055746269692,1306145046561,0641,1031,3502,5546071,824662555-3318151962024023933371,49095319225361442512692692000000
   > Long-term Liabilities 
200
100
200
100
100
75
69
63
94
83
78
68
83
66
47
41
36
33
30
27
23
16
10
4
1,728
343
327
312
1,372
1,331
1,308
1,275
5,639
5,466
5,362
5,228
5,386
5,263
5,151
5,024
5,171
5,092
5,382
1,007
94
2,714
2,653
2,560
2,530
2,417
2,335
2,259
2,202
2,107
2,006
1,920
1,905
1,803
2,250
5,361
6,418
6,837
8,281
8,561
6,224
6,270
6,225
19,108
6,441
6,672
6,401
6,197
6,506
7,366
7,942
8,197
9,345
9,195
9,025
8,989
8,781
82,784
84,516
95,868
106,557
118,772
218,843
72,551
36,926
31,718
31,539
30,814
30,530
31,066
30,664
30,356
29,302
12,218
11,734
27,715
13,025
11,271
10,658
10,020
10,02010,65811,27113,02527,71511,73412,21829,30230,35630,66431,06630,53030,81431,53931,71836,92672,551218,843118,772106,55795,86884,51682,7848,7818,9899,0259,1959,3458,1977,9427,3666,5066,1976,4016,6726,44119,1086,2256,2706,2248,5618,2816,8376,4185,3612,2501,8031,9051,9202,0062,1072,2022,2592,3352,4172,5302,5602,6532,714941,0075,3825,0925,1715,0245,1515,2635,3865,2285,3625,4665,6391,2751,3081,3311,3723123273431,7284101623273033364147668368788394636975100100200100200
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
60,563
62,757
74,578
77,023
98,596
199,359
53,689
0
14,070
14,536
14,479
0
16,208
16,521
16,301
16,615
0
0
0
0
0
0
0
000000016,61516,30116,52116,208014,47914,53614,070053,689199,35998,59677,02374,57862,75760,563000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
10
17
25
31
35
39
42
45
45
37
38
36
33
30
27
22
16
10
4
0
343
327
312
296
270
263
246
4,626
4,469
4,380
4,262
4,435
4,329
4,232
4,121
4,284
4,220
126
167
94
2,714
2,652
2,560
2,476
2,364
2,282
2,205
2,123
2,028
1,927
1,841
1,741
1,638
2,086
5,197
6,222
6,641
8,085
8,365
5,719
5,766
5,721
18,604
6,266
6,496
6,224
6,020
6,331
7,191
7,766
8,022
9,320
9,195
9,025
8,989
8,781
231
275
4,840
9,125
22,382
120,019
192
206
209
205
202
111
93
89
742
32
0
32
32
0
0
0
0
000032320327428993111202205209206192120,01922,3829,1254,8402752318,7818,9899,0259,1959,3208,0227,7667,1916,3316,0206,2246,4966,26618,6045,7215,7665,7198,3658,0856,6416,2225,1972,0861,6381,7411,8411,9272,0282,1232,2052,2822,3642,4762,5602,6522,714941671264,2204,2844,1214,2324,3294,4354,2624,3804,4694,6262462632702963123273430410162227303336383745454239353125171000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,335
2,259
2,202
2,107
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
374
366
318
227
206
165
216
203
0
0
0
25
27
27
0
32
32
32
0
32
32
32
0
32
32
32
32
32
32
0
0
0
0
0
0000032323232323203232320323232027272500020321616520622731836637400000000000000002,1072,2022,2592,33500000000000000000000000000000000000000000000000000
> Total Stockholder Equity
10,800
8,300
16,800
14,800
13,100
11,831
10,687
9,366
7,552
9,888
7,324
5,609
4,963
4,963
6,651
5,266
3,725
4,062
2,867
8,917
15,048
14,844
22,835
19,349
15,550
17,228
14,973
11,855
23,471
21,412
18,860
15,893
21,693
23,747
36,018
32,531
31,035
27,599
23,567
21,002
19,106
15,818
37,191
67,531
60,562
58,704
51,334
50,918
46,503
57,665
55,008
50,745
47,315
39,692
35,833
30,765
34,355
39,932
29,197
61,755
52,455
128,742
121,836
116,733
111,227
103,117
180,562
193,140
175,687
170,972
161,994
146,882
123,282
105,849
123,433
162,023
142,393
112,998
111,396
103,613
86,936
77,909
53,617
33,694
3,435
184,325
186,264
323,904
461,141
581,606
508,554
453,572
399,669
355,085
297,671
266,697
222,363
199,214
169,372
138,160
117,349
94,442
96,739
73,540
73,54096,73994,442117,349138,160169,372199,214222,363266,697297,671355,085399,669453,572508,554581,606461,141323,904186,264184,3253,43533,69453,61777,90986,936103,613111,396112,998142,393162,023123,433105,849123,282146,882161,994170,972175,687193,140180,562103,117111,227116,733121,836128,74252,45561,75529,19739,93234,35530,76535,83339,69247,31550,74555,00857,66546,50350,91851,33458,70460,56267,53137,19115,81819,10621,00223,56727,59931,03532,53136,01823,74721,69315,89318,86021,41223,47111,85514,97317,22815,55019,34922,83514,84415,0488,9172,8674,0623,7255,2666,6514,9634,9635,6097,3249,8887,5529,36610,68711,83113,10014,80016,8008,30010,800
   Common Stock
0
0
0
0
0
30,492
42,258
42,287
42,287
47,639
34
34
34
89
40
40
50
50
51
53
64
70
70
18
18
19
19
19
29
30
31
31
36
39
44
44
44
44
44
44
44
44
86
102
103
103
103
103
105
127
127
127
135
135
135
137
144
180
180
208
210
240
60
60
61
61
72
72
72
72
73
74
74
75
78
90
90
91
91
94
97
98
99
99
101
146
159
168
187
209
210
210
217
227
248
249
253
263
268
270
23
23
26
26,051
26,0512623232702682632532492482272172102102091871681591461019999989794919190907875747473727272726161606024021020818018014413713513513512712712710510310310310310286444444444444444439363131302919191918187070645351505040408934343447,63942,28742,28742,25830,49200000
   Retained Earnings -1,710,838-1,685,672-1,653,435-1,622,965-1,597,961-1,564,032-1,528,497-1,487,848-1,433,385-1,395,601-1,287,103-1,209,856-1,102,908-1,042,739-960,599-906,197-881,858-901,030-772,327-739,786-702,124-679,033-649,646-620,426-587,131-562,115-555,476-523,356-501,850-467,716-458,236-434,838-408,605-387,845-369,141-361,098-343,146-348,740-342,492-331,910-324,499-317,321-306,610-295,789-280,334-249,457-238,604-229,760-229,101-222,479-218,346-210,091-204,615-200,073-197,251-194,838-188,545-187,135-179,518-177,224-169,879-166,930-156,277-152,813-149,237-146,893-142,869-139,847-141,939-137,318-132,841-128,755-123,500-120,059-116,976-114,270-102,712-99,521-97,193-87,907-83,894-80,224-77,882-76,202-62,474-54,546-53,148-53,327-51,752-50,361-47,362-38,239-45,396-43,684-38,239-35,569-33,409-31,506-29,598-27,200-25,200-22,900-20,000-17,400
   Accumulated Other Comprehensive Income 
-600
-700
-700
11,000
11,000
10,902
-102
-102
244
-102
-102
-102
-1,555
-102
3,707
3,718
-102
-1,785
-1,785
-7,500
-1,960
-1,960
-1,960
-1,960
-2,012
-3
-16
-16
-30
-17
-47
-66
-49
56
67
117
108
-674
-915
-1,422
6
22
45
87
106
111
109
117
3
1
-3
-5
35
65
65
93
73
67
-96
-98
-76
-72
-47
-110
-251
-192
-324
3,654
2,708
2,909
3,514
2,659
1,328
782
1,181
560
-117
-461
-598
-282
-529
290
732
700
473
-1,457
-610
-248
-256
-266
-266
-258
-282
-458
-650
-885
-699
-583
-691
-751
-663
-676
-690
-623
-623-690-676-663-751-691-583-699-885-650-458-282-258-266-266-256-248-610-1,457473700732290-529-282-598-461-1175601,1817821,3282,6593,5142,9092,7083,654-324-192-251-110-47-72-76-98-96677393656535-5-3131171091111068745226-1,422-915-6741081176756-49-66-47-17-30-16-16-3-2,012-1,960-1,960-1,960-1,960-7,500-1,785-1,785-1023,7183,707-102-1,555-102-102-102244-102-10210,90211,00011,000-700-700-600
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
254,956
255,238
257,236
257,839
258,113
259,636
263,897
278,290
278,570
341,980
348,110
435,183
439,145
441,281
443,328
445,739
529,555
532,559
534,005
537,131
546,251
552,753
556,718
563,229
589,891
663,223
665,776
668,845
674,017
690,931
707,794
727,167
731,819
735,018
742,647
957,963
1,087,745
1,205,843
1,367,407
1,542,261
1,551,348
1,556,528
1,609,590
1,642,420
1,693,674
1,700,717
1,710,656
1,728,031
1,733,826
0
0
0
0
0
000001,733,8261,728,0311,710,6561,700,7171,693,6741,642,4201,609,5901,556,5281,551,3481,542,2611,367,4071,205,8431,087,745957,963742,647735,018731,819727,167707,794690,931674,017668,845665,776663,223589,891563,229556,718552,753546,251537,131534,005532,559529,555445,739443,328441,281439,145435,183348,110341,980278,570278,290263,897259,636258,113257,839257,236255,238254,95600000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
28,800
29,000
40,400
29,000
29,300
36
36
590
590
590
51,077
51,074
0
52,338
53,265
53,260
57,104
58,945
59,147
78,838
93,146
94,616
104,948
105,185
105,451
114,403
114,489
114,561
137,740
138,374
138,934
139,427
150,460
156,493
173,226
174,310
170,731
171,098
171,331
171,617
171,869
172,030
203,990
237,221
237,578
238,008
238,257
239,243
241,233
254,787
254,956
255,238
257,236
257,839
258,113
259,636
263,897
278,290
278,570
341,980
348,110
435,183
439,145
441,281
443,328
445,739
529,555
532,559
534,005
537,131
546,251
552,753
556,718
563,229
589,891
663,223
665,776
668,845
674,017
690,931
707,794
727,167
731,819
735,018
742,647
957,963
1,087,745
1,205,843
1,367,407
1,542,261
1,551,348
1,556,528
1,609,590
1,642,420
1,693,674
1,700,717
1,710,656
1,728,031
1,733,826
1,736,603
1,740,954
1,748,530
1,783,075
1,758,950
1,758,9501,783,0751,748,5301,740,9541,736,6031,733,8261,728,0311,710,6561,700,7171,693,6741,642,4201,609,5901,556,5281,551,3481,542,2611,367,4071,205,8431,087,745957,963742,647735,018731,819727,167707,794690,931674,017668,845665,776663,223589,891563,229556,718552,753546,251537,131534,005532,559529,555445,739443,328441,281439,145435,183348,110341,980278,570278,290263,897259,636258,113257,839257,236255,238254,956254,787241,233239,243238,257238,008237,578237,221203,990172,030171,869171,617171,331171,098170,731174,310173,226156,493150,460139,427138,934138,374137,740114,561114,489114,403105,451105,185104,94894,61693,14678,83859,14758,94557,10453,26053,26552,338051,07451,077590590590363629,30029,00040,40029,00028,800



5.3. Balance Sheets

Currency in USD. All numbers in thousands.